{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:57:01Z","timestamp":1775012221981,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/s0197-4580(03)00086-1","type":"journal-article","created":{"date-parts":[[2003,6,21]],"date-time":"2003-06-21T08:37:35Z","timestamp":1056184655000},"page":"273-281","source":"Crossref","is-referenced-by-count":257,"title":["Neurochemical diagnosis of Alzheimer\u2019s dementia by CSF A\u03b242, A\u03b242\/A\u03b240 ratio and total tau"],"prefix":"10.1016","volume":"25","author":[{"given":"Piotr","family":"Lewczuk","sequence":"first","affiliation":[]},{"given":"Hermann","family":"Esselmann","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[]},{"given":"Juan Manuel","family":"Maler","sequence":"additional","affiliation":[]},{"given":"Andreas Wolfram","family":"Henkel","sequence":"additional","affiliation":[]},{"given":"Maria Kerstin","family":"Henkel","sequence":"additional","affiliation":[]},{"given":"Oliver","family":"Eikenberg","sequence":"additional","affiliation":[]},{"given":"Christof","family":"Antz","sequence":"additional","affiliation":[]},{"given":"Wolf-Rainer","family":"Krause","sequence":"additional","affiliation":[]},{"given":"Udo","family":"Reulbach","sequence":"additional","affiliation":[]},{"given":"Johannes","family":"Kornhuber","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0197-4580(03)00086-1_BIB1","doi-asserted-by":"crossref","unstructured":"Consensus report of the Working Group. Molecular and biochemical markers of Alzheimer\u2019s disease. The Ronald and Nancy Reagan Research Institute of the Alzheimer\u2019s Association and the National Institute on Aging Working Group. Neurobiol Aging 1998;19(2):109\u201316.","DOI":"10.1016\/S0197-4580(98)00022-0"},{"issue":"8","key":"10.1016\/S0197-4580(03)00086-1_BIB2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/S0197-4580(03)00086-1_BIB3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF-A\u03b242 as diagnostic markers for Alzheimer disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Arch. Neurol."},{"issue":"1\u20133","key":"10.1016\/S0197-4580(03)00086-1_BIB4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","article-title":"CSF total tau, A\u03b242 and phosphorylated tau protein as biomarkers for Alzheimer\u2019s disease","volume":"24","author":"Blennow","year":"2001","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/S0197-4580(03)00086-1_BIB5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/S0197-4580(03)00086-1_BIB6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","article-title":"High cerebrospinal fluid tau and low amyloid \u03b242 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype","volume":"55","author":"Galasko","year":"1998","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/S0197-4580(03)00086-1_BIB7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/S0197-4580(03)00086-1_BIB8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using \u03b2-amyloid(1\u201342) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"issue":"37","key":"10.1016\/S0197-4580(03)00086-1_BIB9","doi-asserted-by":"crossref","first-page":"22908","DOI":"10.1074\/jbc.271.37.22908","article-title":"Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay","volume":"271","author":"Ida","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/S0197-4580(03)00086-1_BIB10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9","article-title":"Cerebrospinal fluid A\u03b242 is increased early in sporadic Alzheimer\u2019s disease and declines with disease progression","volume":"45","author":"Jensen","year":"1999","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/S0197-4580(03)00086-1_BIB11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF03401938","article-title":"Quantification of Alzheimer amyloid \u03b2 peptides ending at residues 40 and 42 by novel ELISA systems","volume":"6","author":"Jensen","year":"2000","journal-title":"Mol. Med."},{"issue":"11 Suppl 5","key":"10.1016\/S0197-4580(03)00086-1_BIB12","first-page":"S4","article-title":"Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"Lobo","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/S0197-4580(03)00086-1_BIB13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0197-4580(98)00014-1","article-title":"Evaluation and use of diagnostic tests in Alzheimer\u2019s disease","volume":"19","author":"Mayeux","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/S0197-4580(03)00086-1_BIB14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/S0197-4580(03)00086-1_BIB15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/S0197-4580(03)00086-1_BIB16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1358\/mf.1998.20.9.487527","article-title":"Basic and clinical studies on ApoE gene typing by line probe assay (LiPA) as a biological marker for Alzheimer\u2019s disease and related disorders: multicenter study in Japan","volume":"20","author":"Nishimura","year":"1998","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/S0197-4580(03)00086-1_BIB17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","article-title":"Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"225","author":"Otto","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/S0197-4580(03)00086-1_BIB18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.54.5.1099","article-title":"Decreased beta-amyloid 1\u201342 in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"54","author":"Otto","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/S0197-4580(03)00086-1_BIB19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"1\/2","key":"10.1016\/S0197-4580(03)00086-1_BIB20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(00)00976-9","article-title":"Cerebrospinal beta-amyloid(1\u201342) in early Alzheimer\u2019s disease: association with apolipoprotein E genotype and cognitive decline","volume":"284","author":"Riemenschneider","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/S0197-4580(03)00086-1_BIB21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay of CSF tau, A\u03b2 1\u201340 and A\u03b2 1\u201342(43) as a biochemical marker of Alzheimer\u2019s disease","volume":"158","author":"Shoji","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/S0197-4580(03)00086-1_BIB22","doi-asserted-by":"crossref","first-page":"d997","DOI":"10.2741\/shoji","article-title":"Cerebrospinal fluid A\u03b240 and A\u03b242: natural course and clinical usefulness","volume":"7","author":"Shoji","year":"2002","journal-title":"Front. Biosci."},{"issue":"1\/2","key":"10.1016\/S0197-4580(03)00086-1_BIB23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(01)02285-6","article-title":"Low cerebrospinal fluid \u03b2-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment","volume":"314","author":"Sj\u00f6gren","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"16","key":"10.1016\/S0197-4580(03)00086-1_BIB24","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0047-6374(01)00304-9","article-title":"Cerebrospinal fluid \u03c4 and \u03b2-amyloid(1\u201342) in dementia disorders","volume":"122","author":"Vanmechelen","year":"2001","journal-title":"Mech. Ageing Dev."},{"issue":"46","key":"10.1016\/S0197-4580(03)00086-1_BIB25","doi-asserted-by":"crossref","first-page":"42645","DOI":"10.1074\/jbc.M102790200","article-title":"Elevation of \u03b2-amyloid peptide 2\u201342 in sporadic and familial Alzheimer\u2019s disease and its generation in PS1 knockout cells","volume":"276","author":"Wiltfang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0197-4580(03)00086-1_BIB26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","article-title":"Highly conserved and disease-specific patterns of carboxyterminally truncated A\u03b2 peptides 1\u201337\/38\/39 in addition to 1\u201340\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation","volume":"81","author":"Wiltfang","year":"2002","journal-title":"J. Neurochem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458003000861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458003000861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T14:27:50Z","timestamp":1682519270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458003000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0197458003000861"],"URL":"https:\/\/doi.org\/10.1016\/s0197-4580(03)00086-1","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}